mxf
☆    

Italy,
2014-03-13 21:52
(4116 d 08:57 ago)

Posting: # 12617
Views: 4,719
 

 incomplete data [🇷 for BE/BA]

Dear All,
after seeing other post in this forum, I would like to clear and point out the state of the art of incomplete data analysis. I haven't commercial softwares and usually work on R. Bear is a very good package, but it seems to be unable for performing analysis with incomplete dataset.

If possible, I would appreciate any possible suggestion about incomplete data anlaysis with R or other not commercial software.

Thank you at all and have patience for my terrible English!

Max
yjlee168
★★★
avatar
Homepage
Kaohsiung, Taiwan,
2014-03-18 11:17
(4111 d 19:32 ago)

@ mxf
Posting: # 12645
Views: 3,752
 

 incomplete data

Dear Max,

❝ […] I haven't commercial softwares and usually work on R. Bear is a very good package, but it seems to be unable for performing analysis with incomplete dataset.


If there is any appropriate statistic model for a incomplete crossover study design (I assume that it's your study design), it should be no problem to build this function into bear. BTW, I am thinking how to present the incomplete data in summary table. For instance, we require to list T/R values for pivotal parameters (such as Cmax and AUCs). If there is no T, then the T/R are all zero; If there is no R, oops! We will get all T/R as "inf"(inity) which is 'not a number (NaN)' in R. Please see this post by Helmut and others. In that post, Helmut got the same 90% CI for Cmax for "subject(sequence) fixed, n=24/23 (i.e., including the incomplete data)" and "subject(sequence) fixed, n=23/23 (without incomplete data)" using a commercial software.

❝ If possible, I would appreciate any possible suggestion about incomplete data analysis with R or other not commercial software.


yes, only if possible... Hope this can help.

All the best,
-- Yung-jin Lee
bear v2.9.2:- created by Hsin-ya Lee & Yung-jin Lee
Kaohsiung, Taiwan https://www.pkpd168.com/bear
Download link (updated) -> here
Dr_Dan
★★  

Germany,
2014-03-18 12:45
(4111 d 18:04 ago)

@ mxf
Posting: # 12649
Views: 3,637
 

 incomplete data

Dear Max
Although not written for BE studies guideline CPMP/EWP/1776/99 could give you some information. One approach would be to determine the highest and lowest possible concentration which still would lead to a positive study result and discuss these concentration in a sensitivity analysis. Unfortunately I am not a statistician and can not provide advice with regard to statistical analysis software.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan
mxf
☆    

Italy,
2014-03-26 18:58
(4103 d 11:50 ago)

@ Dr_Dan
Posting: # 12718
Views: 3,612
 

 incomplete data

Sorry for my delay, but I had a problem in logged in! :confused:

Thanks for all your suggestions. I will think something...

Max
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,676 registered users;
46 visitors (0 registered, 46 guests [including 18 identified bots]).
Forum time: 07:49 CEST (Europe/Vienna)

Complex, statistically improbable things are by their nature
more difficult to explain than
simple, statistically probable things.    Richard Dawkins

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5